Tag Archives: AZ&Me

Millions in Prescription Assistance Provided to Patients in 2015

AZ1256_screen

$617 million in 2015. $5.5 billion since 2010. Hundreds of thousands of patients helped each year.

These are the recent figures from AstraZeneca’s AZ&Me™ Prescription Savings Programs. In 2015, these programs provided more than $617 million in prescription savings to nearly 286,000 patients in the United States. Since 2010, that number has totaled $5.5 billion. But these numbers pale in comparison to the individual stories from patients who receive help paying for their medicines.

At AstraZeneca, we regularly receive letters from people who are kind enough to share with us what the AZ&Me programs mean to them and their families. Here are a few excerpts:

AZPAP Letters 2015-3

We know that our medicines are only helpful to patients if they can access them.  It is stories like these that inspire us to make great medicines while providing support for patients who need it. That’s why we first launched our prescription savings programs more than 35 years ago.

The programs are designed to help qualifying people without prescription drug coverage, those enrolled in Medicare Part D, those who receive their medications through participating healthcare facilities and those who recently faced a financial challenge – such as loss of employment.

  • Individuals without Prescription Drug Coverage: AstraZeneca provides free medicines to qualifying individuals with an annual income at or below $35,000 and families of four with an annual household income at or below $70,000. Certain specialty and oncology medicines are provided free to qualifying individuals with an annual household income up to $100,000 regardless of family size.
  • Part D Beneficiaries: AstraZeneca provides free medicines to qualifying Medicare Part D beneficiaries with an annual income at or below $35,000 and couples with an annual household income at or below $48,000.
  • Healthcare Facilities: AstraZeneca provides free medicines to qualifying non-profit organizations, such as disproportionate share hospitals, community health centers and community free clinics. This program helps provide medicines to qualifying patients at the time and place of treatment.

Learn more about the AZ&Me Prescription Savings Programs – and whether you are eligible for assistance – here.

AZ&Me Prescription Savings Programs Support Patient Access for more than 35 Years

AZ781_screenb

At AstraZeneca, we know that the life-changing medicines we develop will not have an impact on healthcare in the United States if patients are unable to access them. That’s why for more than 35 years we have helped patients afford the medicines they rely on through our patient assistance programs. In 2014, AstraZeneca continued to fulfill our promise to support patients by providing more than $670 million in savings to nearly 383,000 patients in the United States through our AZ&Me Prescription Savings Programs.

This suite of programs is designed to help qualifying people without insurance, those enrolled in Medicare Part D, those who receive their medications through participating health care facilities and those who have faced a financial challenge recently.

Diane Sullivan, Vice President, Market Access & Patient Strategies

“As seen with the recent Supreme Court ruling to uphold healthcare subsidies, the discussions around healthcare in the United States continue to evolve. We remain committed to offering our patient assistance programs as this dialogue progresses,” said Diane Sullivan, Vice President, Market Access & Patient Strategies. “We believe it’s not enough for us to simply make great medicines. We have to help ensure that the people who need those medicines have access to them.”

The healthcare landscape will continue to shift, but AstraZeneca is dedicated to helping patients afford their medicines, even if they aren’t ours. We participate in multi-manufacturer programs like the Partnership for Prescription Assistance and support other organizations with the same goal—increasing access to medicines as well as health care.

Jennifer McGovern, Director of Affordability Programs at AstraZeneca, explains the impact our patient assistance programs have in this video:

As we continue to follow the science to advance research and develop new medicines, the end results of these efforts are always focused on improving patient health and outcomes. Learn more about the AZ&Me Prescription Savings Programs here, or call 1-800-AZandMe (292-6363).

Help Manage Type 2 Diabetes with AZ Patient Support Programs

AZ363_screen

Eat right. Exercise regularly. Sleep well. Take your medications. Managing type 2 diabetes can be challenging, if not sometimes overwhelming. With more than 29 million Americans living with diabetes, AstraZeneca has developed a number of resources that help people living with diabetes navigate their own personal journey with the condition while establishing healthy habits.

Fit2Me

Our newest program, Fit2Me™, offers free type 2 diabetes diet and lifestyle support covering four key areas of diabetes care: food, activity, treatment information and support. Fit2Me allows patients to pick their favorite ingredients, cuisines and fitness activities to build a customized lifestyle plan based on their individual preferences. Love pasta? Fit2Me has 601 diabetes-friendly pasta dishes. Craving dessert? Fit2Me has 902 healthy dessert options. Trying to implement a new cardio routine? Fit2Me has 144 cardio exercises to try out. Fit2Me also provides a personalized digital health coach to help guide each patient’s journey and track their progress.

Market

Fit2Me includes interactive games, team challenges and rewards to encourage individuals to reach their personal goals. But Fit2Me is more than just fun and games – it also includes access to diabetes health resources like type 2 diabetes-trained nurses, certified diabetes educators and assistance verifying insurance coverage.

SteadySTART

AstraZeneca also offers SteadySTART™, a diabetes education program that focuses on helping adults with type 2 diabetes by offering them access to Clinical Educators, who  provide participants education focused on healthy eating and being active, as well as treatment support. SteadySTART has both full-time and on-demand Clinical Educators available to help in face-to-face meetings or over the phone. For those patients who prefer group support, the program offers educational sessions, where educators provide resources and lead discussions and activities.

Clinical Educators help patients get started with their treatment and continue to check in throughout the process to ensure patients are on the right track to reach their goals. With check-ins at day 7, day 30, day 60 and day 90, Clinical Educators offer support and encouragement, answer questions, keep patients on track and help them plan for future success.

AZ&ME Prescription Savings Program

AstraZeneca supports patient access to treatments, including diabetes medications, through the AZ&ME Prescription Savings Programs, which is designed to help provide AstraZeneca medications to qualifying people without insurance, those in Medicare Part D and those who receive their medications through participating healthcare facilities.

Patients without insurance or with Medicare Part D can sign up for the program at no cost and remain enrolled for one calendar year, when they can reapply for the following calendar year. Medicines are mailed to the patient’s home or physician’s office at no cost and the patient, physician or caregiver can request refills.

The AZ&Me Prescription Savings program for healthcare facilities is designed to help provide AstraZeneca medicines to low-income patients through qualifying facilities such as disproportionate share hospitals, community health centers, community free clinics, central fill pharmacies and charitable pharmacies. Facilities enrolled in the program can dispense AstraZeneca medicines at no cost or for a nominal, facility-assessed dispensing fee from their outpatient pharmacy or dispensary to qualified patients.

AstraZeneca values the importance of resources, support and information needed for a more positive health care experience, and continuously looks for ways to support patients who want to better manage their type 2 diabetes.

How Will the Affordable Care Act Impact Rx Savings Programs?

Fundamental changes are coming to the U.S. health system when the new health insurance marketplaces or “exchanges” established as part of the Affordable Care Act take effect on January 1.  Tens of millions more Americans are expected to be covered by health insurance – including prescription drug coverage – as a result of this and other reforms.

We are regularly asked how the new health law will impact our business and what it will mean for our prescription savings programs, which helped 562,000 patients save $1.2 billion on nearly 4.6 million free prescriptions in 2012.

But will there be a need for these savings programs if patients have insurance plans that cover prescription medicine costs? If so, how will the programs be different?

We sat down with Jennifer McGovern, who runs AstraZeneca’s prescription savings programs, to get her perspective about what – if any – changes will be coming to the AZ&Me patient assistance programs.

Watch this brief video for highlights of our conversation, and click here for a full transcript.